one phase exponential decay function (GraphPad Software Inc)
Structured Review
One Phase Exponential Decay Function, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/exponential+decay+function/one+phase+decay+model/bio_rxiv__2025__07__08__663636-289-7-14
Average 90 stars, based on 1 article reviews
Images
Related Articles
Fluorescence:Article Title: YES1 Kinase Mediates the Membrane Removal of Rescued F508del-CFTR in Airway Cells by Promoting MAPK Pathway Activation via SHC1 Article Snippet: .. The initial rate of fluorescence decay (QR), an indicator of the rate of halide transport by CFTR [ ], was derived by fitting the curves to an Derivative Assay:Article Title: YES1 Kinase Mediates the Membrane Removal of Rescued F508del-CFTR in Airway Cells by Promoting MAPK Pathway Activation via SHC1 Article Snippet: .. The initial rate of fluorescence decay (QR), an indicator of the rate of halide transport by CFTR [ ], was derived by fitting the curves to an other:Article Title: Adaptive tuning of mutation rates allows fast response to lethal stress in Escherichia coli Article Snippet: The colony count data corresponding to the decrease in CFU/ml were fitted using an Article Title: Protein aggregation mediates stoichiometry of protein complexes in aneuploid cells Article Snippet: Half-life calculations were made by fitting curves to an Article Title: The claustrum is critical for maintaining working memory information Article Snippet: The accuracy and D-prime values of the WM tasks at varying delay durations were modeled using an Concentration Assay:Article Title: Development of a new class of potent and highly selective G protein-coupled receptor kinase 5 inhibitors and structural insight from crystal structures of inhibitor complexes. Article Snippet: G protein-coupled receptor kinase 5 (GRK5) is an important drug development target for heart failure, cardiac hypertrophy, and cancer.. We have designed and developed a new class of highly selective, potent, and noncovalent GRK5 inhibitors.. One of the inhibitors displayed GRK5 IC50 value of 10 nM and exhibited >100,000fold selectivity over GRK2. |
